Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line.

Tissue antigens - 1 May 1996

Torres M J, Ruiz-Cabello F, Skoudy A, Berrozpe G, Jimenez P, Serrano A, Real F X, Garrido F

Abstract excerpt

A combination of immunohistochemical, biochemical, and recombinant DNA techniques were used to investigate class I expression in 26 pancreatic adenocarcinomas and 6 autologous tumor-derived cells. The prevalence of HLA losses was found to be comparable to that observed in other tumor types (> 35%), using monomorphic and locus-specific antibodies. In one patient, the original tumor tissue, a tumor derived cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Alleles
Share to DNA, Complementary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Deletion

Share to Gene Expression Regulation, Neoplastic

Share to Haplotypes

Share to Heterozygote

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 8795137
DOI: 10.1111/j.1399-0039.1996.tb02572.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line.PMID 8795137Read ↗

Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines.Semantic proximity Read ↗

Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms.Semantic proximity Read ↗

Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.Semantic proximity Read ↗

LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.Semantic proximity Read ↗

Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China.Semantic proximity Read ↗

Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sitesSemantic proximity Read ↗

High frequency of altered HLA class I phenotypes in invasive breast carcinomas.Semantic proximity Read ↗

Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts.Semantic proximity Read ↗

Mechanisms of loss of HLA class I expression on colorectal tumor cellsSemantic proximity Read ↗

Loss of HLA haplotype in lung cancer cell lines: implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer.Semantic proximity Read ↗

Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.